Human Research Switzerland Human Research Switzerland
Legal Notice & Data Protection
Contact & Impressum
DE
|
FR
|
EN

Note: This search will not find any studies.

Start study search
Loading...
Your search returned results.
of pages
No results found for ""
Back to search results
General information
  • Study Phase Phase 2 (ICTRP)
  • Recruitment status recruitment ongoing (BASEC/ICTRP)
  • Trial sites
    Switzerland
    (ICTRP)
  • Contact Andrea B Rosskopf, MD;Andrea B Rosskopf, MD;Andrea B Rosskopf, MD andrea.rosskopf@balgrist.ch (ICTRP)
  • Data Source(s) ICTRP: Import from 19.04.2023
  • Last update 19.04.2023 07:57
HumRes25139 | NCT02776514

Steroid, Acido Ialuronico o Plasma Ricco di Piastrine contro Placebo per l'Osteoartrite del Ginocchio

  • Study Phase Phase 2 (ICTRP)
  • Recruitment status recruitment ongoing (BASEC/ICTRP)
  • Trial sites
    Switzerland
    (ICTRP)
  • Contact Andrea B Rosskopf, MD;Andrea B Rosskopf, MD;Andrea B Rosskopf, MD andrea.rosskopf@balgrist.ch (ICTRP)
  • Data Source(s) ICTRP: Import from 19.04.2023
  • Last update 19.04.2023 07:57

Type of trial

Interventional

(ICTRP)

Intervention under investigation

Farmaco: Triamcort

(ICTRP)

Disease under investigation

Osteoartrite, Ginocchio

(ICTRP)

Criteria for participation in trial

Criteri di inclusione:

- Gonartrosi Kellgren 1,2 con sintomi

- parlante tedesco

- consenso informato

Criteri di esclusione:

-età inferiore a 18 anni, gonartrosi Kellgren 3 e 4, terapia anticoagulante, malattia infiammatoria
nota o infezione, malattia cardiovascolare NYHA IV, immunosoppressione, controindicazione
per risonanza magnetica, gravidanza, nessun consenso informato, FANS 3 giorni prima dell'iniezione, ecc.
(ICTRP)

Exclusion criteria
not available

Trial sites

Switzerland

(ICTRP)

General Information

Radiology University Hospital Balgrist,

141 44 386 33 11;+41 44 386 3311

(ICTRP)

Scientific Information

Radiology University Hospital Balgrist,

141 44 386 33 11;+41 44 386 3311

(ICTRP)


Academic title
Iniezioni Intra-Articolari di Steroidi, Acido Ialuronico o Plasma Ricco di Piastrine contro Placebo per l'Osteoartrite del Ginocchio (ICTRP)

Trial design
Assegnazione: Randomizzata. Modello di intervento: Assegnazione parallela. Scopo principale: Trattamento. Mascheramento: Doppio (Partecipante, Valutatore dei risultati). (ICTRP)

Primary and secondary end points
Imaging a Risonanza Magnetica;Imaging a Risonanza Magnetica;Valutazione del dolore (ICTRP)

Punteggio WOMAC;Punteggio Tegner (ICTRP)

Registration date
18.02.2016 (ICTRP)

Incorporation of the first participant
01.02.2016 (ICTRP)

Secondary sponsors
Stiftung für Rheumaforschung Zurich;Stiftung Marie-Lou Ringgenberg Bern (ICTRP)

Additional contacts
Andrea B Rosskopf, MD;Andrea B Rosskopf, MD;Andrea B Rosskopf, MD, andrea.rosskopf@balgrist.ch, 141 44 386 33 11;+41 44 386 3311, Radiology University Hospital Balgrist, (ICTRP)

Secondary trial IDs
W-560 (ICTRP)

Results-Individual Participant Data (IPD)
No (ICTRP)

Further information on the trial
https://clinicaltrials.gov/show/NCT02776514 (ICTRP)

Results of the trial

Results summary

not available

Link to the results in the primary register

not available